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Copy number variants (CNVs) in the human genome contribute to bothMendelian and complex traits as well as to genomic plasticity in
evolution. The investigation of mutational rates of CNVs is critical to understanding genomic instability and the etiology of the copy
number variation (CNV)-related traits. However, the evaluation of the CNVmutation rate at the genome level poses an insurmountable
practical challenge that requires large samples and accurate typing. In this study, we show that an approximate estimation of the CNV
mutation rate could be achieved by using the phylogeny information of flanking SNPs. This allows a genome-wide comparison of muta-
tion rates between CNVs with the use of vast, readily available data of SNP genotyping. A total of 4187 CNV regions (CNVRs) previously
identified in HapMap populations were investigated in this study. We showed that the mutation rates for the majority of these CNVRs
are at the order of 105 per generation, consistent with experimental observations at individual loci. Notably, the mutation rates of 104
(2.5%) CNVRs were estimated at the order of 103 per generation; therefore, they were identified as potential hotspots. Additional
analyses revealed that genome architecture at CNV loci has a potential role in incitingmutational hotspots in the human genome. Inter-
estingly, 49 (47%) CNV hotspots include human genes, some of which are known to be functional CNV loci (e.g., CNVs of C4 and b-de-
fensin causing autoimmune diseases and CNVs of HYDINwith implication in control of cerebral cortex size), implicating the important
role of CNV in human health and evolution, especially in common and complex diseases.Introduction
Recent studies have shown that the presence of copy
number variants (CNVs) in the human genome is substan-
tial, and thousands of CNVs have been identified in
human populations.1,2 CNV mutations can introduce
unprecedented genomic instability in both germline and
somatic cells, which would lead to Mendelian diseases
and complex traits, including cancers.3,4 Investigation of
the CNV mutation rate is, therefore, critical to unraveling
the instability of the human genome and in turn the func-
tional impact of CNVs underlying human traits and
diseases.
The inbreeding across hundreds of generations made it
accessible to study the mutation rate for spontaneous
CNVs in the laboratorymouse strains.5 However, the direct
estimation of germline mutation rate for CNVs in the
human genome is technically challenging. Only a few
copy number variation (CNV) loci have been studied
individually by disease-prevalence calculation, pedigree
analysis, sperm typing, or pooled sperm assay,6–11 but
a systematic investigation of the CNVmutation rate across
the genome has yet to be accomplished. The locus-specific
mutation rates for CNV have been observed to be ~100 to
10,000 times higher than those for nucleotide substitution
rates,3 which not only highlights the instability of CNV
regions but also suggests large variation in CNV mutation
rate.
In order to examine whether such a notable variance of
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investigatory mothods6–8,10,11 or instead reflects the pres-
ence of CNV mutational hotspots, a genome-wide analysis
for estimation and comparison of CNV mutation rate is
demanded. In this study, we developed a statistical method
called ‘‘CNVMut’’ to evaluate CNV mutation rate across
autosomes of the human genome by utilizing vast, readily
available genotyping data from human populations. This
proposed method was carefully evaluated and validated
via simulation approaches, and it was applied to identi-
fying mutational hotspots of CNVs in HapMap popula-
tions.
Material and Methods
An Algorithm for Approximately Estimating the CNV
Mutation Rate by Using Flanking SNPs
CNVs can be classified as recurrent CNVs with common break-
points and as nonrecurrent CNVs with variable breakpoints.3
A CNV region (CNVR) is usually defined to combine calls from
different individuals as a grouping of CNVs overlapping or in close
proximity to each other, regardless of the potential architectural
complexity.2,12 In this study, a method was proposed for approxi-
mate estimation of the mutation rate for each CNVR. Each CNVR
was treated as a simple marker with potentially multiple alleles,
each with a distinct copy number (0, 1, 2, etc.). Each individual
carries two such alleles in his or her diploid genome.
The SNPs flanking CNV loci often show strong linkage disequi-
librium (LD) with the CNVs,1,12–14 therefore allowing one to trace
CNV mutation events by using the phylogenies of flanking SNPs
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(ARGs).15 ARGs can describe the relationship of chromosome
sequences from a population back to its common ancestor
through events of mutation, recombination, and coalescence,
which are defined under a Wright-Fisher model with recombina-
tion. According to the impact of historical recombination events,
a series of genealogical trees are embedded in the ARG. Each gene-
alogical tree describes the phylogeny for each SNP, which is also
called a ‘‘marginal tree.’’ Following each marginal tree for the
flanking SNPs, we define the tree with the smallest number of
CNV changes as a surrogate of themost parsimonious genealogical
tree for the CNV locus according to the parsimony criterion. The
number of CNV mutations (including both deletion and duplica-
tion) is summarized on the basis of the most parsimonious tree
and can be converted to an approximate estimation of mutation
rate for the CNV locus by simulations.
A brief summary of our statistical method for indirectly
estimating the CNV mutation rate is illustrated in Figure S1
(available online). First, the program Margarita15 was imple-
mented for the construction of plausible ARGs by the SNPs
flanking each CNV locus in one population. The corresponding
marginal tree for each SNP was obtained in this step as well, the
external nodes representing the inferred haplotypes of geno-
typed individuals, the internal nodes representing the ancestral
haplotypes in previous generations, and the root representing
the common ancestral haplotype. Second, an expectation-maxi-
mization (EM) algorithm was used for inferring haplotypes
involving a CNV marker and its flanking SNPs as described by
Kato et al.,16 and we also modified the algorithm to allow the
input of phase-known data (i.e., the preinferred haplotypes of
flanking SNPs obtained from ARG construction). Third, haploid
copy numbers of a CNV marker were superimposed to corre-
sponding external nodes that represented the preinferred haplo-
types of flanking SNPs for each marginal tree, and they were
inferred for each internal node by traversing all the binary tree
units (BTUs; Figure S1D). Lastly, the number of mutation events
was counted for all BTUs, the smallest count being taken as the
most parsimonious estimator. In particular, deletion events and
duplication events were counted separately along the most parsi-
monious marginal tree, with the assumption that a tree
requiring fewer substitutions is better than one that requires
more, for evaluation of the relative mutation rate between dele-
tion and duplication. This detailed procedure is described in
Appendix A.
Because the real phylogeny was unknown, the average of the
estimator for R plausible ARGs (R ¼ 100 here) was taken. For
example, the cumulative mutation count, M, was estimated by
taking an average of the inferred number of mutations over R
(R ¼ 100 here) plausible ARGs:
M ¼
PR
r¼1
minLl¼1fMrlg
N  R ;
where Mrl is the estimator of the mutation number for the l-th
marginal tree of the r-th plausible ARG, and N is the sample size.
The statistic M measures the minimum effective number of
mutation events instead of mutation rate in a population,
following the parsimony assumption; i.e., the estimation depends
on the observed cumulativemutation events under an assumption
of constant evolution rate. It allows an indirect comparison of
mutation rates between CNV loci and between populations. The
order of magnitude of the mutation rate could be converted
from the M statistic with the use of a simulation approach.The AmericSimulation in Evaluating the Algorithm Performance
Given that the aforementioned algorithm invoked several
assumptions that may not biologically realistic, it was evaluated
via a simulation approach. In particular, we interrogated the effect
of several factors on the estimation ofM, including mutation rate,
effective population size, number of flanking SNPs, sample size,
recombination rate between the CNV locus and its flanking
SNPs, and that between adjacent SNPs. The program SIMCOAL217
was employed in simulating the neutral genetic diversity of a CNV
marker and its flanking SNPs under different mutation rates and
demographic models (see Appendix B).Algorithm Implementation for Real Data
Genotype data for the unrelated samples from the HapMap Phase
II project were included in our analysis: 60 Yoruba in Ibadan,
Nigeria (YRI), 60 Utah residents with ancestry from northern
and western Europe (CEU), and 89 Asians (45 Han Chinese from
Beijing [CHB] and 44 Japanese from Tokyo [JPT]; CHBþJPT). First,
4330 genotyped CNVRs from 22 autosomes, identified by
a previous study in HapMap populations, were investigated.2
Genotypes of the SNPs flanking CNV regions but not involved
in CNVR were obtained from the HapMap website (NCBI build
36, release 24). Second, the genetic distance between each CNVR
and its nearest upstream and downstream SNPs was calculated
according to the local recombination rate estimation obtained
from the HapMap website (NCBI build 36) (Figure S2). The CNVRs
with a genetic distance of > 0.1cM to its flanking SNPs were
excluded from further analysis, so as to minimize the effect of
high recombination rate between a CNVR and its flanking SNPs
on the estimation of M. Overall 4187 CNVRs were enrolled in
the following analyses.
The proposed method, CNVMut, was implemented to estimate
both the statistic M and the proportion of deletion mutation for
each CNV locus by using a total of 20 flanking SNPs for each pop-
ulation, respectively. Pairwise comparisons of the estimates of M
among three HapMap populations were conducted by Spear-
man’s correlation test with the use of all of the CNVs and/or
the exclusion of those CNVs with the largest decile of Fst defined
by Weir and Cockerham.18 Fst was calculated according to allele
frequencies estimated during the CNV allele inference by EM
algorithm.
For comparison of the mutation rate of CNVs between popula-
tions and detection of mutational hotspots of CNVs, coalescent
simulations were employed in converting the estimates of M to
different orders of the mutation rate. The simulated data with
different mutation rates of CNVs at order of magnitudes
(5 3 107, 5 3 106, 5 3 105, 5 3 104, and 5 3 103 per gener-
ation) were respectively produced by an extension of SIMCOAL2
under the proper selection of a demographic model for each pop-
ulation.19 The demographic model used in coalescent simulations
for three populations (YRI, CEU, and CHBþJPT) is illustrated in
Table S1. In each simulation under a proper demographic model,
individuals (60 for the YRI model, 60 for the CEU model, and 89
for the CHBþJPT model) with a CNV at a given mutation rate and
20 flanking SNPs with a minor allele frequency (MAF) > 0.01 were
simulated. The recombination rate of adjacent loci, including that
between a CNV marker and its flanking SNPs and that between
adjacent SNPs, was assumed to be 105 per generation, based
upon the evidence including the following: (1) the estimation of
M is robust when the recombination rate between adjacent loci
is less than 103 per generation (Figures S3E and S3F); (2) thean Journal of Human Genetics 87, 494–504, October 8, 2010 495
Figure 1. Distribution of the Estimates
of M in Three HapMap Populations
The distribution of the estimates of M for
3147 polymorphic CNVRs in YRI (A),
2360 polymorphic CNVRs in CEU (B),
and 1615 polymorphic CNVRs in
CHBþJPT (C) is plotted. The range of M
corresponding to a given mutation rate is
indicated in the upper part of each plot
(black for ~105 per generation and red
for ~103 per generation). The range of M
for a given mutation rate indicates the
2.5–97.5 percentile, based on 1000 coales-
cent simulations, which are based upon
properly selected demographic models for
each population.genetic distances between CNV loci to their flanking SNPs were
less than 0.1cM and 3.96 3 103 cM on average; and (3) the
average recombination rate of the human genome is ~108 per
generation per bp,20,21 and the SNP density of HapMap Phase II
is 1.14 per kb.22
Mutational hotspots for CNVs were identified according to the
approximate estimation of the mutation rate converted from the
estimates of M. Some potential differentiating features between
mutational hotspots and the remaining loci, including the
adjacency to segmental duplications (SDs; alternatively termed
low-copy repeats [LCRs]),23,24 the recombination rate between
the CNVR and its flanking SNPs, the CNVR size and the mecha-
nisms underlying CNV formation, were compared by Fisher’s
exact test or the Mann-Whitney test. The location information
of SDs was obtained from the UCSC Genome Browser (hg 18)
for examining whether CNVs overlapped with SDs or not. The
recombination rate between the CNVR and its flanking SNPs
was obtained from the HapMap website (NCBI build 36). The
genetic diversity of the CNVR was measured by the inferred
heterozygosity according to allele frequencies estimated by the
EM algorithm. The CNV formation mechanisms were obtained
from Conrad et al.2
In addition, the potential association of the relative contribu-
tion of deletion versus duplication in the mutation rate with the
different CNV formation mechanisms was also investigated by
the Mann-Whitney test.496 The American Journal of Human Genetics 87, 494–504, October 8, 2010Results
Evaluation of the Performance
of the Estimation
of M Using Simulated Data
The performance of the statistic M,
under both circumstances of consid-
ering demographic events or not, was
carefully evaluated and validated via
simulation approaches. Simulations
illustrated that the estimates of M in-
crease with increasing mutation rates
and can be affected by the demo-
graphic model. However, the number
of flanking SNPs used in constructing
ARGs, sample size, and recombination
rate between adjacent loci (especiallywhen recombination rate is < 103 per generation) has
only very limited effects on the estimation ofM (Appendix
B and Figure S3).
The Estimation of M for the CNVRs Identified
in HapMap Populations
A set of 4330 polymorphic CNVRs as recently identified in
three HapMap populations,2 including 60 YRI, 60 CEU,
and 89 CHBþJPT, was investigated in this study. A total
of 4187 (96.7%) of these CNVRs have close flanking SNPs
with a genetic distance of 0.1 cM or less and were included
in the additional analyses. The estimates of M showed
a very diverse distribution in all three populations
(Figure 1). Notably, the estimates of M are significantly
correlated in all pairwise comparisons among three conti-
nental populations (p < 105), especially when excluding
the CNVRs with pairwise Fst in the largest decile
(Figure S4), suggesting the consistency of the estimation
of M among populations.
Approximate Estimation of Mutation Rates
for the CNVRs Identified in HapMap Populations
Considering the observation that the statistic M can be
affected by the demographic history of human
populations,we converted the estimates ofM to the approx-
imate mutation rate by using a simulation approach under
the proper demographic model in each population and
made M comparable across populations. The distribution
of M according to each 1000 simulations under different
demographic models19 and at different mutation rates
(5 3 107, 5 3 106, 5 3 105, 5 3 104, and 5 3 103 per
generation) is shown in Figure S5 (e.g., the mean5 SD of
M is 0.258 5 0.174 for YRI, 0.158 5 0.157 for CEU, and
0.150 5 0.151 for CHBþJPT under the mutation rate of
5 3 105 per generation; 1.10 5 0.198 for YRI, 1.11 5
0.152 for CEU, and 1.12 5 0.153 for CHBþJPT under the
mutation rate of 5 3 103 per generation). The range of
mutation rates selected for simulation was based on the
contention that locus-specific mutation rates for CNV are
approximately 100 to 10,000 times greater than nucleotide
substitution rates, i.e., ~106 to 104 per generation.3 The
range of M (2.5–97.5 percentile) for a given mutation rate
in each population (Figure 1) provides an approximate esti-
mationof theorder ofmagnitudeof theCNVmutation rate.
Similar to the findings of a wide range of variability of
mutation rates among different CNV loci in the laboratory
mouse strain,5 the estimation of the CNV mutation rate in
human populations also showed variances of orders of
magnitude across the human genome. Among the 4187
CNVRs investigated in the estimation of M, the mutation
rates for most loci were estimated at the order of 105 per
generation. However, the mutation rates for CNVRs could
reach the order of 103 per generation, and these CNVRs
are likely mutational hotspots. A total of 104 (2.5%) poten-
tial hotspots were identified in three HapMap populations
(Figure S6). All of the identified CNV mutational hotspots
are listed in Table S2. Interestingly, 49 (47%) of these iden-
tified CNV hotspots involve known genes of the human
genome, suggesting their implications in biological func-
tions and human health (Table 1).
Notably, these estimators of CNV mutation rate are in
concordance with experimental observations at individual
loci. For example, mutation rates of two CNVRs involving
the a-globin genes (chr16:162,083–167,514 and
chr16:164,519–165,801, NCBI build 36) were evaluated
at the order of ~105 in this study, consistent with the
molecular findings in two previous studies.7,8 In addition,
the CNVR of human b-defensin genes (chr8:7,330,051–
7,342,809, NCBI build 36) was suggested to be amutational
hotspot in all three populations in this study. Interestingly,
this psoriasis-associated b-defensin locus25 was previously
reported among the fastest-mutating CNVs, with a germ-
line mutation rate of 7 3 103 per gamete, revealed by
a pedigree-based approach.11
Genomic Architecture and Rearrangement
Mechanisms Underlying Hotspots
We also studied some genomic features of CNV loci
between candidate hotspots (72 in YRI, 37 in CEU, and
22 in CHBþJPT) and nonhotspots (3075 in YRI, 2323 in
CEU, and 1593 in CHBþJPT) to investigate the potentialThe Americcause of a CNV hotspot. We found that about 60% of hot-
spots overlap with SDs, whereas only< 20% of nonhotspot
CNVRs involve SDs; p ¼ 7.63 3 1015 (Fisher’s exact test)
for YRI, p ¼ 4.39 3 1012 for CEU, and p ¼ 7.62 3 109
for CHBþJPT (Figure 2A).
In addition, no significant differences between hotspots
and nonhotspots were observed for the recombination rate
between the CNVR and its flanking SNPs; p ¼ 0.138
(Mann-Whitney test) for YRI, p ¼ 0.971 for CEU, and
p ¼ 0.903 for CHBþJPT (Figure 2B). In contrast, the CNVR
sizes at the mutational hotspots are larger than those at
the remaining loci; p ¼ 0.007 (Mann-Whitney test) for
YRI, p ¼ 0.042 for CEU, and p ¼ 9.07 3 105 for CHBþJPT
(Figure 2C). The genetic diversity of the CNVR, measured
bythe inferredheterozygosity, is significantlyhigher forhot-
spots than that for nonhotspots as well; p < 105 (Mann-
Whitney test) for all of the populations (Figure 2D).
The CNV formation mechanism has been hypothesized
to affect mutation rate. The nonallelic homologous recom-
bination (NAHR) mechanism was previously proposed to
be a major mechanism underlying CNV formation.23 For
example, NHAR was shown to account for > 99% of the
neuropathy-associated CNVs in the 17p12 region.26
In addition, the loci of NAHR-mediated CNVs have been
regarded as ‘‘hotspots’’ in a previous study.27 Here, we
studied the data of CNV formation mechanisms provided
by Conrad et al.2 and found that the NAHR-mediated
events were more frequent at CNV hotspots than at the re-
maining loci, but not significantly; p ¼ 0.0518 (Fisher’s
exact test) for YRI, p ¼ 0.154 for CEU, and p ¼ 0.0629 for
CHBþJPT (Figures 2E and 2F), suggesting the involvement
of the NAHR mechanism in generating CNV hotspots.
These findings shed light on the understanding of
genome architecture and rearrangement mechanisms
underlying CNV mutations in the human genome.
Reevaluation of the Relative Mutation Rate
of Deletion versus Duplication
The CNV mutation rates associated with deletion
and duplication (alternatively, loss and gain) can be interro-
gated separately in order to investigate the respective contri-
bution of deletion and duplication in CNV mutation. It has
been proposed that deletions occur more frequently than
duplications for NAHR-mediated CNVs, reflecting the lack
of intrachromatid NAHR events in duplication rearrange-
ment.10 The deletion to duplication ratio of ~2:1 was
observed consistently at three autosomal CNV loci in a
pooled sperm PCR assay.10 At the 421 NAHR-mediated
CNV loci (both hotspots and nonhotspots) investigated in
this study, the proportion of deletion events was estimated
to be 0.7745 0.395 (mean5 SD) for YRI, 0.7155 0.436 for
CEU, and0.66750.448 forCHBþJPT. In contrast, at the182
VNTR-mediated CNV loci, the proportion of deletion events
is0.49950.472 forYRI, 0.35250.458forCEU,and0.3945
0.474 for CHBþJPT. The proportion of deletion mutation
events was significantly different between NAHR-medi-
ated CNVRs and VNTR-mediated CNVRs (Mann-Whitneyan Journal of Human Genetics 87, 494–504, October 8, 2010 497
Table 1. The Potential CNV Mutational Hotspots Involving One or More Genes
CNV ID Chr. Start (hg18) End (hg18) Location Gene(s)
YRI CEU CHBþJPT
M
Deletion
(%) M
Deletion
(%) M
Deletion
(%)
CNVR95_full 1 17548473 17551517 1p36.13 PADI4 0.730 0.0 0.555 26.2 0.489 61.0
CNVR116_full 1 25457812 25537782 1p36.11 RHD 0.671 0.5 0.714 0.0 0.445 0.0
CNVR299_full 1 109988369 110060631 1p13.3 GSTM1, GSTM2,
GSTM4, GSTM5
0.696 7.2 0.610 26.2 0.703 62.5
CNVR299.4 1 110016535 110046454 1p13.3 GSTM1, GSTM2,
GSTM4, GSTM5
0.757 0.0 0.399 0.0 0.379 0.0
CNVR481_full 1 204622578 204670033 1q32.1 SRGAP2 0.424 0.0 0.747 2.1 0.672 0.0
CNVR485.1 1 205763104 205821509 1q32.2 CR1 0.592 0.1 0.762 0.0 0.681 0.0
CNVR932.1 2 112761633 112766181 2q13 ZC3H6 0.565 0.7 0.538 0.0 0.779 0.2
CNVR2151.1 4 166377398 166378505 4q32.3 KLHL2 0.795 0.9 0.806 0.0 0.721 0.0
CNVR2664.1 5 159282379 159283692 5q33.3 ADRA1B 0.765 0.1 0.776 0.0
CNVR2728.1 6 200650 329973 6p25.3 DUSP22 0.403 0.3 0.718 0.0 0.802 1.2
CNVR2843.3 6 32066855 32093500 6p21.32 C4A, C4B 0.739 2.0 0.602 0.0 0.600 0.0
CNVR3130.1 6 160431936 160432431 6q25.3 IGF2R 0.629 0.0 0.755 0.0 0.588 0.0
CNVR3426.2 7 64204377 64274741 7q11.21 INTS4 0.833 1.7 0.807 0.0
CNVR3447.1 7 71682534 71684330 7q11.22 TYW1B 0.746 0.0 0.760 0.2 0.499 2.4
CNVR3561_full 7 126301909 126340192 7q31.33 GRM8 0.589 0.1 0.792 0.0
CNVR3585_full 7 141388076 141441024 7q34 MGAM 0.459 1.0 0.827 14.8 0.745 25.6
CNVR3618.4 7 151532774 151539767 7q36.1 MLL3 0.507 0.0 0.725 0.0 0.785 0.0
CNVR3689.1 8 584449 589454 8p23.3 ERICH1 0.731 96.2 0.474 96.3 0.607 100.0
CNVR3771.6 8 7330051 7342809 8p23.1 DEFB105A,
DEFB106A,
DEFB107B
0.773 0.3 0.883 3.3 0.778 4.1
CNVR4280.1 9 41552631 41641509 9p12 ZNF658B 0.737 0.0 0.647 0.0 0.792 0.0
CNVR4685.1 10 33229325 33230534 10p11.22 ITGB1 0.610 0.0 0.637 0.0 0.808 0.1
CNVR4729.3 10 51158267 51158937 10q11.23 PARG 0.398 2.9 0.829 0.0 0.686 0.0
CNVR5084.1 11 17166514 17167872 11p15.1 PIK3C2A 0.676 99.8 0.049 100.0
CNVR5436.1 12 11917753 11918281 12p13.2 ETV6 0.687 100.0 0.048 100.0 0.467 100.0
CNVR6188.1 14 73064141 73121720 14q24.3 HEATR4,
ACOT1,
ACOT2
0.762 0.1 0.569 0.0 0.224 0.0
CNVR6538_full 15 97007643 97011339 15q26.3 IGF1R 0.770 29.7
CNVR6668.2 16 21641198 21716960 16p12.1-
p12.2
OTOA 0.210 0.0 0.590 2.3 0.829 0.6
CNVR6764.3 16 68702855 68754003 16q22.1 MRCL, PDPR 0.617 0.0 0.766 0.0 0.625 0.0
CNVR6767.2 16 69404749 69760030 16q22.2 HYDIN, HYDIN2 0.801 0.0 0.667 0.0
CNVR6769_full 16 70646001 70669798 16q22.3 DLP, HP, HPR 0.687 0.0 0.572 0.0
CNVR6852.1 16 86580132 86581743 16q24.2 BANP 0.735 1.2
CNVR6956.1 17 3988918 3989416 17p13.2 ZZEF1 0.703 0.0 0.026 0.0
CNVR7021.1 17 20285952 20335955 17p11.2 LGALS9B 0.907 0.0 0.801 0.0 0.476 2.3
CNVR7098.1 17 36785827 36793150 17q21.1 KRT34 0.762 1.3 0.587 0.7 0.634 15.5
CNVR7144.1 17 53042845 53044836 17q22 MSI2 0.700 100.0 0.028 100.0 0.028 100.0
CNVR7154_full 17 55766887 55768922 17q23.2 USP32 0.710 100.0 0.017 100.0 0.021 100.0
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Table 1. Continued
CNV ID Chr. Start (hg18) End (hg18) Location Gene(s)
YRI CEU CHBþJPT
M
Deletion
(%) M
Deletion
(%) M
Deletion
(%)
CNVR7370.1 18 62370731 62372179 18q22.1 CDH7,
CDH19
0.829 100.0 0.077 100.0 0.012 100.0
CNVR7492_full 19 2860172 2861422 19p13.3 ZNF57 0.761 100.0 0.022 100.0 0.019 100.0
CNVR7540.1 19 11900599 11907033 19p13.2 ZNF700 0.848 3.3 0.034 0.5 0.025 0.0
CNVR7702.1 19 56823616 56842035 19q13.33 SIGLEC5,
SIGLEC14
0.898 70.1 0.865 64.6 0.417 72.8
CNVR7708.1 19 58014801 58053170 19q13.41 ZNF28, ZNF468 0.686 0.0 0.665 0.0 0.618 0.2
CNVR7726.1 19 60168046 60169697 19q13.42 NLRP2, NLRP7 0.693 0.8 0.320 5.0 0.102 12.7
CNVR7849.1 20 41705581 41707310 20q13.12 IFT52 0.813 98.5 0.770 100.0 0.011 100.0
CNVR8030.1 21 43794624 43797920 21q22.3 HSF2BP 0.740 99.9 0.676 97.5 0.012 100.0
CNVR8066.1 21 46434207 46435262 21q22.3 LSS 0.716 1.7
CNVR8067.1 21 46481946 46483100 21q22.3 MCM3APAS,
MCM3AP
0.693 96.8 0.562 99.6 0.011 100.0
CNVR8085.1 22 16871523 16873123 22q11.21 MICAL3 0.542 1.0 0.796 6.4 0.782 1.5
CNVR8136.1 22 31257932 31258517 22q12.3 SYN3 0.394 0.6 0.752 0.2 0.623 1.6
CNVR8171_full 22 41209145 41335158 22q13.2 SERHL, SERHL2, RRP7A,
RRP7B, POLDIP3
0.708 0.2 0.705 0.6 0.636 0.2test: p< 105 for YRI, p< 105 for CEU, and p¼ 2.713 105
for CHBþJPT). These observations suggested the predicted
overrepresentation of deletion versus duplication at the
CNV loci mediated by the NAHRmechanism.Discussion
Previous approaches for estimating the mutation rate for
CNVs by using molecular assays or prevalence calculation
are locus specific, and only a few CNV loci have ever been
studied in the human genome. The statistical method of
CNVMut proposed in this study makes it accessible to
evaluate the CNV mutation rate across the human
genome, though approximately, by using vast, readily
available genotyping data of human populations.
In this method, we employed LD relationship between
the CNV loci and their flanking SNPs in tracing CNVmuta-
tion events by the plausible genealogical histories recon-
structed by the flanking SNPs. Because CNV alleles are
not readily determined experimentally, we used the EM
algorithm to infer haploid copy number with the assis-
tance of the preinferred haplotypes of flanking SNPs.
According to our evaluation, the accuracy of the CNV
alleles’ inference was comparable to that of the SNP haplo-
type inferred by the EM algorithm.28 The error rate can be
controlled by less than 5%, especially with the help of
flanking SNPs (data not shown). In order to eliminate the
inflated estimation of theM statistics caused by the uncer-
tainty of the CNValleles’ inference as much as possible, we
conducted such inference for every plausible ARG andThe Americaveraged the analysis (i.e., the M statistics). In addition,
simulations were also conducted with genotype data
when converting the statisticM to an approximate estima-
tion of the CNV mutation rate.
The statistic M was proposed to measure the minimum
effective counts of CNV mutation events based on plau-
sible ARGs constructed by flanking SNPs. The estimation
of M was based upon an assumption of the parsimony
criterion with a constant evolution rate. Any violation of
this assumption, such as different changes of different
copies following different mutation rates, would lead to
an underestimation of the statistic M.
In this study, actual mutation rates were obtained by
rescaling M with the use of coalescent simulations. The
genetic diversity of a CNV locus and its flanking SNPs
was simulated under the assumption of neutrality. Because
this estimate does not account for purifying selection, it
probably represents a lower bound on the true rate. In
addition, we examined the possible effect of varying local
recombination rate on mutation rate estimation for the
CNVRs involving the genes of a-globin and b-defensins
in YRI population and found that the estimation of CNV
mutation rate for both loci was unaffected (~105 and
~103 per generation, respectively), similar to those
estimated under the assumption of a constant recombina-
tion rate (105 per generation). It has also been illustrated
(Figure S3) that both the number of flanking SNPs (when>
10) used to construct plausible ARGs and the recombina-
tion rate between adjacent loci have limited and slight
effects on the estimation of M. Therefore, it is proper
to use 20 flanking SNPs and an assumed constantan Journal of Human Genetics 87, 494–504, October 8, 2010 499
Figure 2. Comparison of CNVRs with Potential Hotspots and Nonhotspots
The percentage of CNVRs overlapping with SDs (A), the recombination rate (cM/kb) between a CNVR and its flanking SNPs (B), the
CNVR size (C), the genetic diversity of the CNVR (D), the percentage of NAHR-mediated CNVRs (E), and the percentage of VNTR-medi-
ated CNVRs (F) is illustrated for CNVRswith nonhotspots and potential hotspots. Statistically significant differences (p< 0.001) between
the hotspot group and the nonhotspot group are indicated by asterisks.recombination rate of 105 per generation between adja-
cent loci for coalescent simulations to convert the
estimates of M into mutation rate.
Using this method, we identified 104 potential muta-
tional hotspots for CNVRs in three HapMap populations
(YRI, CEU, and CHBþJPT). The hotspots were defined as
CNVRs with an approximate estimation of mutation rate
at ~103 per generation. Figure S6 illustrates the consis-
tency of 104 potential hotspots among three populations.
More than one-half of the potential hotspots identified in
CEU and CHBþJPT can be confirmed in another popula-
tion. However, more specific hotspots were observed in
YRI. It should be noted that ancient CNV mutations are
more likely to be observed in Africans than in other popula-
tions, given that non-Africans experienced extreme genetic
drift, especially during their migration out of Africa.
Genetic diversity for hotspots is significantly higher
than that for nonhotspots (Figure 2D), which is consistent500 The American Journal of Human Genetics 87, 494–504, Octoberwith the observation, gathered from CNVs on the human
Y chromosome, that high mutation rate has driven exten-
sive structural polymorphism on Y.29 High genetic diver-
sity is expected to be the consequence of high mutation
rate, rather than a cause for mutational hotspots, because
mutation is regarded as a force underlying genetic diver-
sity. The enrichment of SDs at hotspots supports the
contention that SDs act as mutation seeds during genome
evolution and that SD-rich regions are vulnerable to
genome rearrangements mediating CNVs.23,24 Interest-
ingly, more CNVs at hotspots than at nonhotspots are
found to be mediated by the NAHR mechanism taking
place between two homologous SDs (Figure 2E). It has
also been shown that the other knownmechanisms under-
lying CNV formation, including DNA repair by joining of
double-strand break ends, as well as DNA replication
errors, are incident to genomic regions rich in repeat and
repetitive sequences,30–33 reflecting the regional genome8, 2010
architecture inciting genomic instability and mutational
hotspots of CNV.
Somedisease-associated lociwere identified asCNVmuta-
tional hotspots in this study (Table 1). Besides the psoriasis-
associated CNVs of b-defensin genes mentioned above, we
also identified aCNVhotspot involving the gene of comple-
ment componentC4 (with isotopesC4A [MIM 120810] and
C4B [MIM 120820]) in association with human systemic
lupus erythematosus (SLE [MIM 152700]).34 In addition,
twomutational hotspots involve a glutathione conjugation
gene,GSTM1 [MIM138350], with implication in cancer risk
and drug resistance.35 The homozygous deletion of RHD
(MIM 111680) can cause RhD-negative blood type.36 The
CNVs at the RHD locus were reported to be highly polymor-
phic in human populations2,37 and were also identified as
CNV hotspots in this study. The IGF1R locus (MIM
147370) is also among CNV hotspots, and its deletion
CNVs can cause gene haploinsufficiency in association
with short status and other developmental defects in chil-
dren born small for gestational age.38 Notably, genomic
instability was also shown in some CNVs mediating neuro-
psychiatric traits, including the GRM8 [MIM 601116] and
HYDIN [MIM610812] loci.GRM8 encodes theglutamatergic
receptor 8, and the patient with CNV-mediated GRM8 gene
rearrangement presented autism and severemental retarda-
tion.39 The instable locus of hydrocephalus-associated
HYDIN in 16q22.2 experienced an event of duplication
and insertion into 1q21.1 during primate evolution, and
the CNVs at both of theseHYDIN loci can lead to abnormal
brain size, i.e., microcephaly ormacrocephaly.40 These find-
ings of functional CNV loci as mutational hotspots suggest
an important role of CNV in human diseases and evolution.
In addition, though we applied this method to the pub-
lished CNV genotyping data provided by Conrad et al.2
and to genotypes of SNPs from HapMap database, various
genotyping data produced by current prevailing whole-
genome SNP arrays, e.g., Affymetrix Genome-Wide
Human SNP Array 6.0 and Illumina Human1M-Duo DNA
Analysis BeadChip, can also be applied to this method.
In summary, we propose a statistical method, CNVMut,
to achieve an approximate estimation of CNV mutation
rates using genotyping data of human populations and
to identify potential CNV mutational hotspots. The
enrichment of repeat sequence at mutational hotspots
sheds light on the understanding of genome architecture
and rearrangement mechanisms underlying CNV muta-
tions in the human genome, and the observation of func-
tional CNV loci in hotspots implicates an important role of
CNV in human health and evolution.Appendix A: An Algorithm for Estimating CNV
Mutations by Using Flanking SNPs
General Description of the Algorithm
A brief summary of the algorithm is illustrated in Figure S1
and uses an example of a CNV (0 for homozygous deletion,The Americ1 for heterozygous deletion, 2 for homozygous wild-type)
and five SNPs (0 and 1 for homozygotes, H for heterozy-
gote) flanking the CNV. For each CNV locus, the genotypes
of both the CNVand its flanking SNPs for individuals from
a population are used for analysis. The ARG is constructed
by using genotypes of flanking SNPs with the haplotypes
inferred simultaneously (step 1). An EM algorithm is
employed in determining the phase of CNV alleles with
the assistance of the inferred haplotypes of flanking SNPs
in step 1 (step 2). The marginal trees describing the genea-
logical history of each SNP are then obtained according to
the ARG constructed in step 1 (step 3). Each inferred CNV
allele in step 2 is then superimposed to an external node of
each marginal tree as step 4 (e.g., solid and open circles for
deletion and wild-type, respectively). The CNV states for
the internal nodes are then inferred on the basis of the
rules as defined in the subsequent section (step 5), and
the number of CNV mutation events is counted (step 6).
Because the real ARG is unknown, steps 1–6 are repeated
R times, and a statistic M is defined as the arithmetic
average of the event counts of CNVmutation in the R plau-
sible ARGs. We have developed a program called CNVMut,
which is available online, to implement the algorithm.
ARG Inference Algorithm
A method of ARG was previously proposed for reconstruc-
tion of the phylogeny on the basis of mutation, recombi-
nation, and coalescence.15 Figure S1B illustrates an ARG
of SNP haplotypes. Haplotype 2 and haplotype 4 are
respectively derived from the recombination of haplotype
3 and haplotype 5. Haplotype 5 and haplotype 6 are
conjunct by a mutation at site 4. When two haplotypes
are identical for all SNPs, they can be conjunct by a coales-
cence event. For each site of the haplotype, there is a gene-
alogical tree, called a ‘‘marginal tree,’’ embedded in the
ARG according to the impact of historical recombination
events. Figure S1D illustrates the marginal trees for sites
1–3, site 4, and site 5 from left to right, respectively.
In this study, we employed the software Margarita15 to
infer ARGs and marginal trees on the basis of the geno-
types of SNPs flanking a CNV. Margarita uses a heuristic
algorithm to infer plausible ARGs by minimizing the
number of involved recombination locally. This algorithm
allows rapid computation and can handle both unphased
and missing data.
Haplotype Inference Algorithm
An EM-based algorithm for inferring haplotype was
proposed by Excoffier and Slatkin41 for the analysis of
SNP data. Kato et al.16 extended the algorithm for CNV
data. The difference between the algorithm for CNV and
that for SNP is in the initial step during the generation of
the possible haplotype pairs for a given genotype. As for
the genotype of a SNP marker with its alleles coded as
0 and 1, a haplotype containing allele 0 and another con-
taining allele 1 are the possible haplotype pair at this site.
The alleles of a CNV loci are not readily distinguishable,an Journal of Human Genetics 87, 494–504, October 8, 2010 501
because the possible allele/haplotype pair for a CNV with
diploid copy number of 4 can be either [0 copies/4 copies],
[1 copy/3 copies], or [2 copies/2 copies] at this locus.
To superimpose CNValleles to the marginal tree requires
the inference of CNV alleles with the assistance of the pre-
inferred haplotypes of flanking SNPs provided by the soft-
ware Margarita. In particular, all possible haplotypes
encompassing the CNV and its flanking SNPs were
enumerated, and an EM algorithm was applied to calculate
and update the frequencies of haplotypes in order to
obtain the maximum likelihood estimation, following
the iteration previously described.16,41 In the end, the
most probable haplotype pair for each individual is ob-
tained for subsequent analysis.
Counting CNV Mutations
Each CNV allele could be superimposed to the external
nodes of each marginal tree based on the inferred haplo-
types, including CNV and flanking SNPs. Then, we infer
the haploid copy number at each internal node of the
tree. Let a binary tree unit (BTU) be denoted as a subtree
with three nodes (two ends and one vertex) as shown in
Figure S1D. The haploid copy number of each node is
referred to as its state hereafter, and the state of each
internal node is inferred according to the following rules:
(1) Only when the states of both ends of the BTUs have
been inferred can the state of the vertex be inferred. (2) If
the state of any end is ancestral (‘‘1’’ is set as the ancestral
state here), the state of the vertex is set as the ancestral one.
(3) If none of the states of two ends is ancestral and they
are mutually exclusive, the union of the states of two
ends is taken as the state of the vertex. (4) If none of the
states of two ends is ancestral but not mutually exclusive,
the intersection of the states of two ends is taken as the
states of the vertex and both ends. (5) The procedure
continues until all nodes of the marginal tree are updated.
Given that the states or haploid copy numbers of all
nodes are inferred, the number of mutations can be
counted for each marginal tree by traversing all of the
BTUs of the marginal tree. If the states of the two ends
are different, one mutation is added to the count. If L
SNPs are used in ARG construction, L marginal trees and
L estimators of the number of mutation are obtained.
The smallest count is taken as the estimator of the plau-
sible ARG, which can be considered as an approximate
estimator of the most parsimonious mutation process.
Notably, deletion mutation events and duplication muta-
tion events can be counted separately along this parsimo-
nious marginal tree, in order to compare mutation rates
between deletion and duplication. Because the real ARG
is unknown, the average of the estimator for R plausible
ARGs (R ¼ 100 here) is taken. For example, the statistic
describing a CNV mutation can be expressed as
M ¼
PR
r¼1
minLl¼1fMrlg
NR
;502 The American Journal of Human Genetics 87, 494–504, Octoberwhere Mrl is the estimator of the mutation number for the
l-th marginal tree of the r-th plausible ARG and N is the
sample size.Appendix B: Evaluation of the Performance
of the Estimation of M with the Use
of Simulated Data
Simulation Data
The program SIMCOAL217 was employed in simulating the
neutral genetic diversity of a CNV marker and its flanking
SNPs under variable mutation rates and different demo-
graphic models. Because SIMCOAL2 allows short tandem
repeat (STR) markers but not CNVs, simulations were con-
ducted by using a STR marker as a surrogate of CNV. The
most common allele of STR was converted to the ancestral
allele with a haploid copy number of 1. The STR alleles
shorter than the common one were set as 0 for the CNV,
and the STR alleles larger than the common one were set
as 1 þ d for the CNV, where d is the difference of copy
number between the STR alleles and the common allele.
In the simulation, a constant population with an effec-
tive population size (Ne) of 5000 was assumed and the
sample size was set to 100 individuals. A haploid consisting
of a CNV along with 20 flanking SNPs with an MAF greater
than 0.01 was generated. The mutation rate for CNV was
set to 5 3 105 per generation, and the rate of recombina-
tion between adjacent loci (including that between the
CNV locus and its flanking SNPs and that between
adjacent SNPs) was 105 per generation. However, when
the effect of an individual factor was interrogated,
numerous values were taken in simulation. The genotype
of a diploid individual was then generated by combining
two randomly selected haploids.
The Estimates of M Increase along with Increasing
Mutation Rates
The estimates of M increase along with the increasing
mutation rate of CNV (5 3 107, 5 3 106, 5 3 105, 5 3
104, and 5 3 103 per generation) for simulated data
(Figure S3A), indicating that M could allow a comparison
of the mutation rates among CNV loci. For example, the
distributions ofM are significantly (p < 105; Mann-Whit-
ney test) different between the mutation rates of 5 3 105
and 5 3 103 per generation.
Effect of Demographic Models on the Estimation ofM
Simulation analysis showed that the estimates of M
increase along with increasing effective population size,
even under the same mutation rate. For example, the
estimates of M increase along with the increasing effective
population size (2500, 5000, and 10,000) under a given
mutation rate (Figure S3B). These observations suggest
that population demographic profiles must be taken into
consideration when converting the estimates of M to
mutation rate.8, 2010
The Estimation of M Is Not Affected by the Number
of Flanking SNPs or the Sample Size
We also investigated the possible effect of the number of
flanking SNPs (10, 20, 30, 40, and 50) and the sample
size (50, 100, 150, 200, and 250) on the estimation of M.
The simulation results showed that neither an increasing
number of flanking SNPs nor increasing sample size would
affect the estimation of M, besides a slight reduction of
variance (Figure S3C and S3D).
Effect of Recombination Rate between a CNV
and Its Flanking SNPs on the Estimation of M
The LD relationship between CNVs and flanking SNPs was
employed in our proposed method. The impact of recom-
bination rate (106, 105, 104, 103, 102, and 101 per
generation) between a CNV locus and its flanking SNPs
on the estimation of M was evaluated. Our observations
indicated that the estimation of M was robust when the
recombination rate was less than 103 per generation
and that a recombination rate of 103 per generation or
above can inflate the estimates of M (Figure S3E).
Effect of Recombination Rate between Adjacent SNPs
on the Estimation of M
The effect of recombination rate (107, 106, 105, 104,
and 103 per generation) between adjacent SNPs on the
proposed algorithm for estimating M was also examined
by simulation. It was illustrated that the estimation of M
was robust to varying recombination rates between adja-
cent SNPs (Figure S3F).Supplemental Data
Supplemental Data include six figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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